Triple therapy in COPD: new evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide

The goals of COPD therapy are to prevent and control symptoms, reduce the frequency and severity of exacerbations, and improve exercise tolerance. The triple combination therapy of inhaled corticosteroids (ICSs), long-acting beta(2) agonists (LABAs), and long-acting muscarinic antagonists (LAMAs) ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Dave, Corradi, Massimo, Spinola, Monica, Papi, Alberto, Usmani, Omar S, Scuri, Mario, Petruzzelli, Stefano, Vestbo, Jørgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5638574/
https://www.ncbi.nlm.nih.gov/pubmed/29062229
http://dx.doi.org/10.2147/COPD.S146822

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5638574/
https://www.ncbi.nlm.nih.gov/pubmed/29062229
http://dx.doi.org/10.2147/COPD.S146822

Ejemplares similares